13F HOLDINGS REPORT
Pivotal bioVenture Partners Investment Advisor LLC
Quarter ended Q3 2023 · Filed August 11, 2023 · Accession 0001012975-23-000330
Total Value
$303.3M
Positions
11
Other Managers
1
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KARUNA THERAPEUTICS INC | 48576A100 | 782,008 | $169.6M | 55.90% |
| 2 | VAXCYTE INC | PCVX | 793,036 | $39.6M | 13.06% |
| 3 | OCULIS HOLDING AG | OCSAW | 2,381,196 | $29.4M | 9.68% |
| 4 | INOZYME PHARMA INC | 45790W108 | 3,661,518 | $20.4M | 6.72% |
| 5 | RALLYBIO CORP | RLYB | 2,404,644 | $13.6M | 4.49% |
| 6 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 1,105,309 | $10.5M | 3.47% |
| 7 | FUSION PHARMACEUTICALS INC | 36118A100 | 1,560,982 | $7.3M | 2.40% |
| 8 | VIGIL NEUROSCIENCE INC | 92673K108 | 560,595 | $5.3M | 1.74% |
| 9 | EXSCIENTIA PLC | 30223G102 | 770,500 | $4.6M | 1.50% |
| 10 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,891,467 | $2.4M | 0.80% |
| 11 | ALIGOS THERAPEUTICS INC | ALGS | 743,215 | $721,662 | 0.24% |